3-Oxo-6-oxa-2-azatricyclo 5.4.2. unadecene-4-carboxylate

Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Parasitic organism or component thereof or substance...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

2602453, C07D49804, A61K 3142

Patent

active

044155840

ABSTRACT:
Compounds of the formula (II): ##STR1## wherein R.sub.1 is hydrogen or alkyl of 1 to 4 carbon atoms, CO.sub.2 R.sub.2 is a carboxyl group, a pharmaceutically acceptable salt thereof or a pharmaceutically acceptable esterified carboxyl group, are useful for their .beta.-lactamase inhibitory activity and to synergize the antibacterial activity of penicillins and cephalosporin.

REFERENCES:
patent: 4036969 (1977-07-01), Stirling
Merck Index, p. 1005.
Melmon, "Clinical Pharmacology", p. 47.
"Nomenclature of Organic Chemistry", 1979 Edition 1. U.P.A.C., pp. 202, 206.
Naming Organic Compounds, 2nd Edition, Banks, p. 191.
An Introduction to Chemical Nomenclature, 4th Ed., Cahn, p. 98.
Condensed Chemical Dictionary, 9th Edition, p. 16.
Organic Chemistry, vol. 1 (FINAR), p. 222.
"Organic Chemistry, 2nd Edition 1964", Cram et al., pp. 90-91.
Kingzett's Chemical Encyclopedia, 9th Edition, p. 18.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

3-Oxo-6-oxa-2-azatricyclo 5.4.2. unadecene-4-carboxylate does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with 3-Oxo-6-oxa-2-azatricyclo 5.4.2. unadecene-4-carboxylate, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 3-Oxo-6-oxa-2-azatricyclo 5.4.2. unadecene-4-carboxylate will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-159503

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.